Richard Francis

Chief Executive Officer, Sandoz at Novartis AG

Richard Francis

Richard Francis

Chief Executive Officer, Sandoz at Novartis AG

Overview
Career Highlights

Sandoz, Inc.

RelSci Relationships

1751

Number of Boards

2

Birthday

1969

Age

51

Relationships
RelSci Relationships are individuals Richard Francis likely has professional access to. A relationship does not necessarily indicate a personal connection.

Division Head, Alcon at Novartis AG

Relationship likelihood: Strong

Chief Financial Officer at Novartis AG

Relationship likelihood: Strong

Chief Executive Officer at Novartis AG

Relationship likelihood: Strong

Former Chairman of the Board, President & Chief Executive Officer at Mettler-Toledo International, Inc.

Relationship likelihood: Strong

Chief Executive Officer at Mettler-Toledo International, Inc.

Relationship likelihood: Strong

Former Chief Executive Officer at Novartis AG

Relationship likelihood: Strong

Group General Counsel of Novartis at Novartis AG

Relationship likelihood: Strong

Chief People & Organization Officer at Novartis AG

Relationship likelihood: Strong

Chief Executive Officer at Implenia AG

Relationship likelihood: Strong

Former Group General Counsel at Novartis AG

Relationship likelihood: Strong

Paths to Richard Francis
Potential Connections via
Relationship Science
You
Richard Francis
Chief Executive Officer, Sandoz at Novartis AG
Education
BA in Economics

Manchester Metropolitan University is one of the most popular universities in the UK, in the UK’s most popular student city.

Career History
Chief Executive Officer
2014 - 2019

Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ.

Chief Executive Officer & Division Head
2014 - 2019

Sandoz International GmbH develops and manufactures generic pharmaceuticals. It produces finished dosage forms of such off-patent drugs as diabetes treatment Glucophage, GERD drug Prilosec, and cholesterol. The company was founded in 1996 and is headquartered in Holzkirchen, Austria.

Chief Executive Officer, Sandoz
Current - 2019

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Boards & Committees
Independent Director
2016 - Current

Mettler-Toledo International, Inc. manufactures and markets precision instruments for use in laboratory, industrial and food retailing applications. It also provides analytical instruments for use in life science, reaction engineering and real-time analytic systems used in drug and chemical compound development and process analytics instruments used for in-line measurement in production processes. Mettler-Toledo also supplies end-of-line inspection systems used in production and packaging for food, pharmaceutical and other industries. The company operates through the following segments: U. S. Operations, Swiss Operations, Western European Operations, Chinese Operations and Other. The U.S. Operations segment represents certain of the company's marketing and producing organizations located in the United States. The Western European Operations segment includes marketing and producing organizations in Western Europe, excluding operations located in Switzerland. The Swiss Operations segment includes marketing and producing organizations located in Switzerland as well as extensive R&D operations that are responsible for the development, production and marketing of precision instruments, including weighing, analytical and measurement technologies for use in a variety of industrial and laboratory applications. The Chinese Operations segment represents marketing and producing organizations located in China. Its market organizations are geographically focused and are responsible for all aspects of the company's sales and service. The Operating segments that exist outside these reportable segments are included in other segment. Mettler-Toledo International was founded in 1991 and is headquartered in Columbus, OH.

Member, Executive Committee
2014 - 2019

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Richard Francis. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Richard Francis's profile does not indicate a business or promotional relationship of any kind between RelSci and Richard Francis.